Here we show that VPRBP levels are tightly controlled by USP2, a deubiquitinase that binds and stabilizes VPRBP, and that loss of USP2 function can activate p53 responses, including its tumor suppressive effects. This evidence concerns the gene TP53 and neoplasm.